Embedded Files
HYPOLIPIDEMIC EFFICACY OF ZINGIBER OFFICINALE EXTRACT IN COMPARISON WITH FENOFIBRATE, ROSUVASTATIN AND EZETIMIBE IN HYPERLIPIDEMIC RATS
HYPOLIPIDEMIC EFFICACY OF ZINGIBER OFFICINALE EXTRACT IN COMPARISON WITH FENOFIBRATE, ROSUVASTATIN AND EZETIMIBE IN HYPERLIPIDEMIC RATS
Kawa F. Dizaye a and Hani H. Mohammed b
Kawa F. Dizaye a and Hani H. Mohammed b
a College of Medicine, Hawler Medical University.
b Department of Pharmacology, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.
Submitted: 25/3/2019; Accepted: 29/7/2019; Published: 21/9/2019
DOI Link: https://doi.org/10.17656/jsmc.10208
ABSTRACT
Background
Zingiber officinale (Ginger) is the most common used herb worldwide due to its great medicinal and culinary properties. The medicinal properties come from its antihyperlipidemic, anti-inflammatory, antiemetic, antimicrobial, anticancer and carminative actions.
Objectives
The present study was designed to evaluate and compare the effectiveness of different doses of Ginger decoction with, rosuvastatin, fenofibrate and ezetimibe on lipid profile, liver function test and MDA level in hyperlipidemic rats.
Methods
Fifty-four rats were divided into two groups. The first group included 18 rats and have subdivided into three subgroups each having 6 rats. The first subgroup served as a control. The second and the third subgroup received (2 ml and 4 ml) of ginger extract (10% W/V) daily respectively. The second group included 30 hyperlipidemic rats and they were subsequently subdivided into six subgroups each of 6 rats. The first subgroup served as positive control. The second subgroups received single doses of ginger (10% W/V). The third, fourth and sixth subgroups received Rosuvastatin (15 mg /kg), Fenofibrate (30mg/kg) and Ezetimibe (1mg/kg) respectively. At the end of treatment period (six weeks), all of these groups were subjected to various biochemical analysis of blood
Results
After six weeks of therapy, ginger extract significantly reduced serum total cholesterol, TG and LDL-C of hyperlipidemic rats, while it significantly increased serum HDL in both normal and hyperlipidemic rats. Daily administration of fenofibrate for six weeks caused significant reduction in serum TG and LDL-C and significantly increased serum HDL of hyperlipidemic rats. Whereas using of rosuvastatin (15mg/kg) and ezetimibe (1mg/kg) for six weeks lead to significant reduction in serum total cholesterol, TG, LDL-C and significantly increase in serum HDL in hyperlipidemic rats. Dose of 2 ml ginger 10% (W/V) decoction significantly reduced MDA level in normal rats, Furthermore Ginger extract and the other antihyperlipidemic drugs significantly decreased serum MDA level of hyperlipidemic rats. After 6 weeks of daily ingestion of different doses ginger decoction, serum ALP was significantly increased in normal rats. However, liver function test of hyperlipidemic rats was not significantly affected by ginger decoction. In another hand, rosuvastatin caused a significant elevation in serum ALP, while ezetimibe significantly reduced AST of hyperlipidemic rats.
Conclusion
Zingiber officinale decoction was effective as the other antihyperlipidemic agents in improving lipid profile. Although ginger has an antioxidant effect, but prolonged administration may have a hazardous hepatic side effect.
KEYWORDS
Hyperlipidemia, Ginger, Rosuvastatin, Fenofibrate, Ezetimibe.
References
1. Walker R. Clinical Pharmacy and Therapeutics E-Book. Elsevier Health Sciences; 2012. 389-411 p.
2. Katzung BG, Masters SB, Trevor AJ. Basic & clinical pharmacology. A Lange medical book. 2012. xiii, 1229 .
3. Harvey R. Lippincott’s Illustrated Reviews: Pharmacology, 5th Edition. Medicine & Science in Sports & Exercise. 2012. p. 265–6.
4-Dizaye K, Jarjees H. Effects of Omega-3 on lipid profile and haematological parameters in hyperlipidemic rats. Middle East Journal of Internal Medicine. 2014 Sep 1;7(3).
5. Giacosa A, Morazzoni P, Bombardelli E, Riva A, Porro GB, Rondanelli M. Can nausea and vomiting be treated with Ginger extract? Eur Rev Med Pharmacol Sci. 2015;19(7):1291–6.
6. Dizaye KF, Chalaby LA. Hypolipidemic efficacy of Trigonella Foenum seeds in comparison with Rosuvastatin and Fenofibrate in hyperlipidemic rats. Middle East Journal of Family Medicine. 2015 Sep 1;13(6).
7. Habib SHM, Makpol S, Hamid NAA, Das S, Ngah WZW, Yusof YAM. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics. 2008;63(6):807–13.
8. Lete I, Allué J. The Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy. 2016;11–7.
9. Baliga MS, Haniadka R, Pereira MM, D’Souza JJ, Pallaty PL, Bhat HP, Popuri S. Update on thechemopreventive effects of ginger and its phytochemicals. Critical reviews in food science and nutrition. 2011 Jul 1;51(6):499-523.
10. Mani DN, Bawankule D, Saroj BK. Hyperlipidemic model: Studying lipid profile in small experimental animal. Int. J. Pharm. Pharm. Sci. 2012;4:337-40.
11. Munshi RP, Joshi SG, Rane BN. Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance and markers for coronary heart disease. Indian J Pharmacol. 2014;46(3):270–6.
12. Dhande SR, Gursahani MS, Kadam VJ. Standardization of cholesterol suspension induced hyperlipidemia in rats. 2014;3(12):1107–23.
13. Prasad S., Kumar S, Vajpeyee S., Bhavsar V. To establish the effect of ginger-juice zingiber officinale (zingiberaceae) important parameters of lipid. Int J Pharma Sci Res. 2012;3(4):352–6.
14. Berroukche A, Attaoui A, Loth M. Comparative study between effects of ethanol extract of Zingiber officinale and Atorvastatine on lipid profile in rats. J Pharmacogn Phyther. 2016;8(8):155–62.
15. Tabibi, H., Imani, H., Atabak, S., Najafi, I., Hedayati, M. and Rahmani, L., 2016. Effects of ginger on serum lipids and lipoproteins in peritoneal dialysis patients: a randomized controlled trial. Peritoneal Dialysis International, 36(2), pp.140-145.
16. ElRokh ES, Yassin NA, El-Shenawy SM, Ibrahim BM. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology. 2010 Dec 1;18(6):309-15.
17. Al-Noory AS, Amreen A-N, Hymoor S. Antihyperlipidemic effects of ginger extracts in alloxan-induced diabetes and propylthiouracil-induced hypothyroidism in (rats). Pharmacognosy Res. 2013 Jul;5(3):157–61.
18. Sun B, Xie Y, Jiang J, Wang Y, Xu X. Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia. Lipids Health Dis. 2015;1–6.
19. Li W, Wang D, Song G, Zuo C, Qiao X, Qin S. The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in rats. Lipids Health Dis. BioMed Central Ltd; 2010;9(1):131.
20. Oikawa S, Yamashita S, Nakaya N, Sasaki J, Kono S. Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study. 2017;24:77–94.
21. Ansari JA, Bhandari U, Pillai KK, Haque SE. Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats — A preliminary study. Indian J Exp Biol. 2012;50(March):216–22.
22. Rosenson RS, Otvos JD, Hsia J. Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study. Diabetes care. 2009 Jun 1;32(6):1087-91.
23. Ruggenenti P, Cattaneo D, ROTA S, ILIEV I, Diadel O, Paranova A, et al. Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes. A prospective randomized double-blind clinical trial. Diabetes Care. 2010;33(9):1954–6.
24. Kumagai N, Miura S, Zhang B, Noda K, Saku K. Effects of ezetimibe on hypercholesterolemia in the lipid profile in patients with metabolic syndrome: Zenith Trial. IJCME. Elsevier Ireland Ltd; 2013;1:7–12.
25. Phan BAP, Dayspring TD, Toth PP. Ezetimibe therapy : mechanism of action and clinical update. Vasc Health Risk Manag. 2012;415–27.
26. Aznar J, Santos M teresa, Valles J, Sala J. Serum malondialdehyde-like material ( MDA-LM ) in acute myocardial infarction. J Clin Pathol. 1983;36:712–5.
27. Singh Z, Karthigesu IP, Singh P, Kaur R. Use of malondialdehyde as a biomarker for assessing oxidative stress in different disease pathologies: A review. Iran J Public Health. 2014;43(3):7–16.
28. Ahmad N, Sulaiman S, Mukti NA, Murad NA, abd hamid noor aini. Effects of Ginger Extract (Zingiber officinale Roscoe) on Antioxidant Status of Hepatocarcinoma Induced Rats. Malaysian J Biochem Mol Biol. 2006;14:7–12.
29. Abd-allah OM, SHARAF EL-DIN abeer A. The Possible Protective Effect of Ginger Against Intestinal Damage Induced by Methotrexate in Rats. Med J Cairo Univ. 2013;81(1):1073–84.
30. Yang R, Shi Y, Hao G, Li W, Le G. Increasing Oxidative Stress with Progressive Hyperlipidemia in Human : Relation between Malondialdehyde and Atherogenic Index. J Clin Biochem Nutr. 2008;43(3):154–8.
31. Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2011;49(4):893–7.
32.Taha NM, Mandour AA, Lebda MA. Antioxidative and cardio-protective effects of ethanolic extract of ginger on triton wr-1339 induced hyperlipidemia in rats. Int J Chem Res. 2014;6(1):153–8.
33. Rasyidah TI, Suhana S, Kaswandi MA, Noah RM. Evaluation of Antioxidant Activity of Zingiber Officinale ( Ginger ) on Formalin-Induced Testicular Toxicity in Rats. J Med Bioeng. 2014;3(3):149–53.
34. Kulkarni RA, Deshpande AR. Anti-inflammatory and antioxidant effect of ginger in tuberculosis. Journal of Complementary and Integrative Medicine. 2016 Jun 1;13(2):201-6.
35. Yu S, Zhou X, Hou B, Tang B, Li J, Zhang B. Protective effect of rosuvastatin treatment by regulating oxidized low-density lipoprotein expression in a rat model of liver fibrosis. Biomedical reports. 2016 Sep 1;5(3):311-6.
36. Elhemely MA, Omar HA, Ain-shoka AA, El-latif HAA, Abo-youssef AM, El Sherbiny GA. Rosuvastatin and ellagic acid protect against isoproterenol-induced myocardial infarction in hyperlipidemic rats. Beni-Suef Univ J Basic Appl Sci. Elsevier Ltd; 2014;3(4):239–46.
37. Yunoki K, Nakamura K, Miyoshi T, Enko K, Kohno K, Morita H, et al. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction. Atherosclerosis. Elsevier Ireland Ltd; 2011;217(2):486–91.
38. Samanta A, Patra A, Mandal A, Roy S, Mandal S, Das K, Sinha B, Kar S, Nandi DK. Physiological Indications and Gut-Microbial Community in Army Personnel in High-Altitude and Base-Line Environments: A Comparative Study. Jordan Journal of Biological Sciences (JJBS). 2018:2141.
39 Attia AMM, Ibrahim FAA, Nabil GM, Aziz SW. Antioxidant effects of ginger ( Zingiber officinale Roscoe ) against lead acetate-induced hepatotoxicity in rats. African J Pharm Pharmacol. 2013;7(20):1213–9.
40. Shalaby MA, Saifan HY. Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats. J Intercult Ethnopharmacol. 2014;3(4):144–9.
41. Santiago LA. Effect of fenofibrate on free radicals in vitro, lipid peroxides, antioxidant enzymes and liver transaminases in hyperlipidemic mice. Int J Res Dev Pharm Life Sci. 2013;2(4):511–8.
42. Sowmya P, Muthiah NS, Susshmitha R, Arvinth A. Study of liver function abnormalities during statin therapy in a tertiary care center. J Chem Pharm Res. 2016;8(7):515–9.
43. Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Liver transplantation. 2009 May 1;15(5):504-8.
44. Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA, Knopp RH, Lipka LJ, LeBeaut AP, Yang B, Mellars LE. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clinical therapeutics. 2001 Aug 1;23(8):1209-30.
© The Authors, published by University of Sulaimani, College of Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Page updated
Report abuse